February 2025 – Volume 166 – Issue 2 : PAIN
PAIN publishes research on the nature, mechanisms and treatment of pain. The journal provides a forum for the dissemination of research in the basic and clinical sciences of multidisciplinary interest.
Related Articles
Laminectomy Adjacent to Instrumented Fusion Increases… : Spine
s uncertain outcomes. The increased mechanical forces at the unfused laminectomy may lead to more ASD. Few studies have examined the development of ASD with…
Pediatric Critical Care Medicine 2025, Volume 26: A New Era … : Pediatric Critical Care Medicine
An abstract is unavailable.
S6, Ep 22- Advocating One Patient at a Time with Julie Baak
The Health Advocates are joined by rheumatology practice manager Julie Baak who talks about how insurance practices like utilization management delay treatme…
Degradomics defines proteolysis information flow from human knee osteoarthritis cartilage to matched synovial fluid and the contributions of secreted proteases ADAMTS5, MMP13 and CMA1 to articular cartilage breakdown
Proteolytic cartilage extracellular matrix breakdown is a major mechanism of articular cartilage loss in osteoarthritis (OA) pathogenesis. We sought to determine the overlap of proteolytic…
Predictors of Health Care Disparities in Fuchs Dystrophy… : Cornea
Academy of Ophthalmology IRIS Registry (Intelligent Research in Sight). Multivariable Cox proportional hazards models were fit to examine the relationships between sociodemographic variables and time…
How is age at menopause and reproductive lifespan… : PAIN
years. Data were collected from the Tromsø study conducted in Norway between 2015 and 2016 (Tromsø7). Chronic pain was assessed using a single question, which…
ACR Journals On Air: Immunology for the Rheumatologist: NETs in Lupus
In this episode we explore the role of Neutrophil Extracellular Traps (NETs) in systemic lupus erythematosus (SLE). Dr. Mariana Kaplan, Chief of the Systemic Autoimmunity…
EULAR: Start inflammatory arthritis therapies ‘without delay’ after cancer remission
Targeted therapies for active inflammatory arthritis should be started “without delay” for patients with cancer in remission, according to new EULAR points to consider published…
Home | RheumNow
Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for Rheumatologists and individuals…
